Myeloma

Top Story

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017

Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood cancers, thus limiting referrals, according to study results published in Cancer.

“Our findings are important as they shed light on factors that are potential barriers to hospice referrals,” Oreofe O. Odejide, MD, instructor of medicine at Harvard Medical School and physician at Dana-Farber Cancer Institute, said in a press release. “These findings can be employed to develop targeted interventions to address hospice underuse for patients with blood cancers.”

In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in…

Leukemia & Lymphoma Society names chief medical officer

May 18, 2017
Gwen Nichols, MD, medical hematologist and oncologist in New York, became chief medical officer of the Leukemia & Lymphoma Society this spring. Nichols specializes…
FDA News

FDA clears study of GBR 1342 for multiple myeloma

May 15, 2017
The FDA cleared Glenmark Pharmaceuticals’ investigational new drug application to initiate a phase 1 study that will evaluate GBR 1342 for treatment of patients…
CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in…
More »
Video

VIDEO: Peter Voorhees, MD, reviews ‘extremely important’ proteasome inhibition data from ENDEAVOR

June 9, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

In the Journals Plus

Lack of transfusion capabilities linked to underuse of hospice for blood cancers

May 22, 2017
Hematologic oncologists appeared to value hospice but may be concerned about the adequacy of services like transfusion for patients with blood…

In the Journals Plus

Rare cancers represent 20% of US cancer diagnoses

May 19, 2017
Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society…

Leukemia & Lymphoma Society names chief medical officer

May 18, 2017
Gwen Nichols, MD, medical hematologist and oncologist in New York, became chief medical officer of the Leukemia & Lymphoma Society this spring…

FDA News

FDA clears study of GBR 1342 for multiple myeloma

May 15, 2017
The FDA cleared Glenmark Pharmaceuticals’ investigational new drug application to initiate a phase 1 study that will evaluate GBR 1342 for…

Perlmutter Cancer Center names program leader

May 4, 2017
Ahmad Samer Al-Homsi, MD, MBA, will lead a new bone marrow transplantation program designed to treat blood cancers at NYU Langone’s Perlmutter…

Leukemia & Lymphoma Society panel explores ‘tsunami’ of financial burdens, potential of immunotherapy

May 3, 2017
Patients continue to face a “tsunami” of financial burdens associated with cancer care, but advances in immunotherapy and precision…

FDA News

FDA issues warnings about fraudulent cancer treatments

April 25, 2017
The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or…

FDA News

FDA grants orphan drug designation to tasquinimod for multiple myeloma

April 13, 2017
The FDA granted orphan drug designation to tasquinimod for the treatment of multiple myeloma, according to the drug’s manufacturer. Tasquinimod…

Patient education pivotal when recommending palliative care

April 12, 2017
Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment…

American Association for Cancer Research inaugurates new leadership

April 6, 2017
Michael A. Caligiuri, MD, has been inaugurated as the 2017-2018 president of the American Association for Cancer Research. Caligiuri —…

More Headlines »
Advertisement
Advertisement